David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.45% |
| 2 | Consumer Discretionary | 10.49% |
| 3 | Communication Services | 9.04% |
| 4 | Healthcare | 8.89% |
| 5 | Financials | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
PUT
Microsoft
MSFT
$3.63T
| $29.5M | 0.03% |
125,000
-172,900
| -58% | -$40.1M |
|
652
Unilever
UL
$140B
| $29.5M | 0.03% |
468,904
+224,890
| +92% | +$14.3M |
|
653
PUT
Royal Caribbean
RCL
$77.7B
| $29.3M | 0.03% |
342,500
+195,500
| +133% | +$15.5M |
|
654
American Financial Group
AFG
$12B
| $29.3M | 0.03% |
256,814
+31,548
| +14% | +$3.26M |
|
|
WBT
655
DELISTED
Welbilt, Inc.
WBT
| $29.3M | 0.03% |
1,802,823
+219,716
| +14% | +$3.3M |
|
656
Sherwin-Williams
SHW
$83.9B
| $29.2M | 0.03% |
118,716
+85,581
| +258% | +$20.4M |
|
657
PUT
MongoDB
MDB
$32.5B
| $29.2M | 0.03% |
109,200
-62,000
| -36% | -$22M |
|
658
CALL
RH
RH
$2.71B
| $29.2M | 0.03% |
48,900
-2,800
| -5% | -$1.38M |
|
659
CALL
Lithia Motors
LAD
$8.18B
| $29.1M | 0.03% |
74,700
+13,400
| +22% | +$4.81M |
|
660
Fox Class B
FOX
$25.8B
| $29M | 0.03% |
831,482
-293,777
| -26% | -$9.85M |
|
661
NVR
NVR
$17B
| $29M | 0.03% |
6,158
-677
| -10% | -$3.04M |
|
662
Ball Corp
BALL
$17B
| $29M | 0.03% |
341,820
-133,945
| -28% | -$11.7M |
|
663
PUT
Zscaler
ZS
$28.6B
| $28.9M | 0.03% |
168,600
+2,000
| +1% | +$397K |
|
664
Chubb
CB
$133B
| $28.8M | 0.03% |
182,257
-57,951
| -24% | -$9.34M |
|
665
Nutrien
NTR
$35.2B
| $28.8M | 0.03% |
534,145
+507,525
| +1,907% | +$27.6M |
|
|
VER
666
DELISTED
VEREIT, Inc.
VER
| $28.8M | 0.03% |
745,110
+679,142
| +1,030% | +$25.4M |
|
667
CALL
ServiceNow
NOW
$133B
| $28.8M | 0.03% |
287,500
-310,500
| -52% | -$32.8M |
|
668
PUT
Procter & Gamble
PG
$339B
| $28.7M | 0.03% |
212,200
-88,100
| -29% | -$11.5M |
|
669
Fox Class A
FOXA
$29B
| $28.7M | 0.03% |
+795,674
| New | +$27.8M |
|
670
PUT
Expedia Group
EXPE
$40.1B
| $28.7M | 0.03% |
166,900
-107,400
| -39% | -$16.5M |
|
671
Lumen
LUMN
$5.88B
| $28.6M | 0.03% |
2,143,423
+2,025,332
| +1,715% | +$25.2M |
|
672
Danaher
DHR
$151B
| $28.6M | 0.03% |
143,253
-16,212
| -10% | -$3.29M |
|
673
Merit Medical Systems
MMSI
$5.39B
| $28.5M | 0.03% |
476,168
-10,199
| -2% | -$584K |
|
|
CPE
674
DELISTED
Callon Petroleum Company
CPE
| $28.5M | 0.03% |
739,019
-671,972
| -48% | -$16.6M |
|
675
AutoNation
AN
$6.55B
| $28.5M | 0.03% |
305,333
+264,686
| +651% | +$21.2M |
|
Similar funds
David Shaw's Q1 2021 Portfolio in Review
As of Q1 2021, David Shaw held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
David Shaw withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, David Shaw opened a new position in Baidu worth $627M.
- David Shaw's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- David Shaw added most to Tesla in Q1 2021, an estimated $862M increase.
- David Shaw's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- David Shaw fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- David Shaw's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- David Shaw opened 825 new positions and closed 730 in Q1 2021.
- David Shaw's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.